| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Pharmacology and Center for Lung and Vascular Biology, University of Illinois College of Medicine, Chicago.
Correspondence to Asrar B. Malik, Department of Pharmacology, University of Illinois at Chicago, College of Medicine, 835 South Wolcott Ave (M/C 868), Chicago, IL 60612. E-mail abmalik{at}uic.edu
| Abstract |
|---|
|
|
|---|
Key Words: transient receptor potential channels Ca2+ influx endothelial vascular barrier permeability lung injury
| Introduction |
|---|
|
|
|---|
Transient receptor potential melastatin (TRPM)2 is an oxidant-activated channel belonging to the TRP family of cation channels. TRPM2,11 first named TRPC7 and later LTRPC-2,12 is a nonselective cation channel widely expressed in mammalian tissues, including the brain, peripheral blood cells such as neutrophils,11,13 bone marrow, spleen, heart, and liver,14 and lungs.15 TRPM2 opening after exposure to oxidants is induced by the binding of the intracellular second messenger adenosine diphosphoribose (ADP-ribose) or related molecules to the Nudix box sequence motif (NUDT9-H)14,16,17 in its carboxyl-terminal domain.14 Because the Nudix box has significant homology with a pyrophosphatase, NUDT9 ADP-ribose hydrolase,17–21 TRPM2 was dubbed a "chanzyme." Besides free ADP-ribose primarily generated from poly(ADP-ribose) polymerase (PARP) activity, NAD (possibly through conversion to ADP-ribose)17–19,22 and cyclic adenosine diphosphoribose (cADP-ribose)22 may also activate TRPM2.
Hydrogen peroxide (H2O2) produced in the cytosol during oxidative stress15 stimulates ADP-ribose formation in the nucleus and mitochondria.23 TRPM2 channels may thus participate in signaling oxidative stress–induced Ca2+ entry, thereby eliciting Ca2+-dependent cellular processes.15,18,23 Although most investigators can demonstrate an indirect action of H2O2 in stimulating ADP-ribose formation in nuclei and mitochondria,23 direct agonist action of H2O2 on TRPM2 is also proposed for myeloid cells.24,25
In addition to full-length functional TRPM2 (TRPM2-L), several TRPM2 isoforms have been identified in human hematopoietic cells, including a short splice variant (TRPM2-S).24 TRPM2-S (short) lacks the entire carboxyl terminus of the long variant, 4 of 6 carboxyl-terminal transmembrane domains, including the putative Ca2+-permeable pore, and functions in a dominant-negative fashion to inhibit TRPM2-L activity.24,25 TRPM2-S directly interacts with TRPM2-L to suppress H2O2-induced Ca2+ influx through TRPM2-L in transfected 293T cells.24 Thus, TRPM2-S is an important isoform of TRPM2 that may modulate channel activity and cell death induced by oxidative stress activation of TRPM2-L.24
Here, we demonstrate that H2O2 at noncytolytic concentrations elicits marked Ca2+ influx via TRPM2 channels, which thereby signals increased endothelial permeability. Inhibition of endogenous TRPM2 expression and function in endothelial cells by RNA silencing, a specific TRPM2-blocking antibody, overexpression of TRPM2-S isoform, or inhibition of ADP-ribose generation significantly decreased H2O2-induced increase in [Ca2+]i and the resulting increase in endothelial permeability. These data demonstrate a critical role of TRPM2 in the mechanism of endothelial barrier disruption following oxidative stress.
| Materials and Methods |
|---|
|
|
|---|
Endothelial Cell Culture and Transfection
Human pulmonary artery endothelial (HPAE) cells (Clonetics, La Jolla, Calif) were cultured in gelatin-coated flasks using endothelial basal medium 2 (EBM2) supplemented with bullet kit additives plus 10% fetal bovine serum, and used in experiments between passages 3 and 6.
Human full-length TRPM2, tagged on its carboxyl terminus with the blue fluorescent protein (BFP)–TRPM2-L, was subcloned into pQBI50 (QbioGene, Carlsbad, Calif). Short splice variant, tagged on its carboxyl terminus with the green fluorescent protein (GFP)–TRPM2-S, was inserted into pTracer-CMV (Invitrogen). HPAE cells grown to 60% to 80% confluence were transfected for 4 hours with 1 µg/mL each BFP–TRPM2-L or GFP–TRPM2-S cDNA or with vector alone (control cells) using LipofectAMINE Plus.26 Cells transfected by TRPM2-L were susceptible to apoptosis; therefore, we added caspase 9 inhibitor (Ac-LEHD-CHO, 20 µmol/L) to the medium. After 48 hours, transfected or control cells forming confluent monolayers were used for experiments. Successful transfection of cells with TRPM2-S or TRPM2-L was verified by detection of GFP (excitation, 478 nm; emission, 535 nm) or BFP (excitation, 380 nm; emission, 435 nm) with laser-scanning confocal microscope (Zeiss LSM 510). Transfection efficiency was 80% to 90%.
Small Interfering RNA Transfection
HPAE cells were transiently transfected with 50 nmol/L each 2 predesigned small interfering (si)RNAs using TransIT-TKO transfection reagent according to the instructions of the manufacturer. siRNAs were targeted to exon 1 or 4 of the TRPM2 mRNA sequence. We cotransfected both siRNAs for maximal knockdown of TRPM2 expression. As a control, we used commercially available nonspecific siRNA. Experiments and RNA extractions were performed at 48 hours after transfections. Transfection efficiency was >75%.
Whole-Cell Patch-Clamp Recording in Endothelial Cells, [Ca2+]i Measurements, Transendothelial Electrical Resistance Measurement, and Western Blotting Analyses
Methods are detailed in the online data supplement.
Detection of TRPM2 by RT-PCR
Two-step RT-PCR was performed using the Eppendorf Mastercycler gradient system (Eppendorf, New York) and real-time PCR using the ABI Prism 7700 Sequence Detection System (Perkin-Elmer, Applied Biosystems). PCR was performed for 36 cycles (denaturation at 94°C for 15 seconds, annealing at 56°C for 30 seconds, and extension at 72°C for 1 minute for 36 cycles). The primers used to amplify the TRPM2-L transcript targeted its carboxyl-terminal region. The forward sequence used was 5'-TCGGACCCAACCACACGCTGTA-3', and the reverse sequence was 5'-CGTCATTCTGGTCCTGGAAGTG-3'. Primers targeting both transcripts (TRPM2-L and -S) were: forward, 5'-GAAGAGCATTTTCCGCAGA-3'; reverse, 5'-ATGAGCTCGCCTTCCTTGT-3'. We used coamplified human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a reference. The amplified products were separated on 1.4% agarose gels.
| Results |
|---|
|
|
|---|
|
Action of H2O2 on Ca2+ Entry
Because the electrophysiological observations suggest that H2O2 can stimulate Ca2+ entry by activating the Ca2+-permeable channel TRPM2-L, we next measured intracellular Ca2+ responses to H2O2 in HPAE cells. We used a "Ca2+ add-back" protocol designed to rule out indirect effects of H2O2 on Ca2+ entry via Ca2+-store depletion (Figure 2). In the absence of extracellular Ca2+, H2O2 application (
300 µmol/L) did not produce a Ca2+ transient, although in the same experiment, Ca2+ repletion (in the continued presence of H2O2) elicited a brisk Ca2+ response. Control experiments showed that Ca2+ repletion per se (no H2O2 added) was completely ineffective in evoking Ca2+ transients (Figure 2). The amplitude of Ca2+-repletion transients depended on the concentration of H2O2 (EC50, 58.6 µmol/L; Figure 2, inset). These results indicate that H2O2 increases intracellular Ca2+ by stimulating Ca2+ entry without provoking Ca2+-store depletion. Interestingly, at a concentration of 500 µmol/L, H2O2 elicited a Ca2+ transient in the absence of extracellular Ca2+, suggesting that H2O2, at the highest level used, releases sequestered Ca2+ (Figure 2). TRPM2 siRNA or TRPM2-blocking antibodies did not block this effect (data not shown).
|
TRPM2 Expression in Endothelial Cells
RT-PCR and Western Blot analysis gave evidence of TRPM2 channel expression in HPAE cells (Figure 3A and 3B). TRPM2 transcript was detected in untreated wild-type HPAE cells and to an even greater extent in TRPM2-L transfected cells (Figure 3A). The channel was not detected in TRPM2 siRNA–treated cells. Western blot analysis showed TRPM2-L protein expression as a prominent band at 171 kDa (Figure 3B). The level of TRPM2 detected in untreated HPAE cells was significantly reduced in TRPM2 siRNA–transfected cells; treatment with control siRNA was ineffective. Cells overexpressing TRPM2-L had a significantly intensified band at 171 kDa by densitometric analysis, confirming specificity of the antibody used.
|
TRPM2 Regulates H2O2-Induced Ca2+ Entry in Endothelial Cells
Monolayers of HPAE cells adhering to glass coverslips had submicromolar levels of intracellular Ca2+ in Ca2+-containing medium (Figure 3C, inset). Addition of H2O2 (300 µmol/L) produced Ca2+ transients (Figure 3D, inset). TRPM2 knockdown (siRNA-transfected HPAE cells) nearly abolished the H2O2 effect (Figure 3E, inset). Anti-TRPM2 blocking antibody (Bethyl Laboratories, Montgomery, Tex) also prevented the H2O2-induced Ca2+ transients (Figure 3F, inset). We added back Ca2+ after first depleting extracellular Ca2+ for less than 5 minutes to rule out indirect effects of H2O2 via Ca2+-store depletion. This alone without H2O2 had no effect on intracellular Ca2+ levels (Figure 3C). In Ca2+-free medium, H2O2 addition of released no intracellular Ca2+, whereas Ca2+ repletion in the continued presence of H2O2 elicited a Ca2+ transient (Figure 3D), which represented the Ca2+ entry stimulated by H2O2. A similar Ca2+-repletion–dependent transient did not occur on TRPM2 depletion with siRNA transfection (Figure 3E) or anti-TRPM2 blocking antibody (5 µg/mL for 8 to 16 hours; Figure 3F). Transfection of HPAE cells with TRPC4 siRNA (as negative control) did not affect the ability of H2O2 to induce Ca2+ entry (Figure 3G). Figure 3G quantifies all data obtained for Ca2+-containing media and for the Ca2+-repletion protocol.
TRPM2 Depletion Reduces H2O2-Mediated Endothelial Hyperpermeability
Increased intracellular Ca2+ causes opening of interendothelial junctions, which is detectable as reduction in transendothelial electrical resistance (TER).5,8–10 Because H2O2 increased intracellular Ca2+, we tested H2O2 for its ability to decrease TER. HPAE cells were grown to confluence on gold microelectrodes and treated with H2O2 (300 to 600 µmol/L), and changes in TER were followed for 4 hours. Recordings of TER in Figure 4A show that H2O2 decreases TER. The effect was transitory; at <500 µmol/L, H2O2-mediated response recovered to basal levels within 2 hours. Results of quantification of the peak TER response at each H2O2 concentration are displayed with curve of best fit (EC50, 254 µmol/L; Figure 4A).
|
We next compared TER responses to H2O2 with or without TRPM2 silencing. To show the effect of siRNAs on TRPM2 protein expression, we transduced HPAE cultures with BFP-tagged TRPM2-L, a fluorescent fusion protein forming functional channels. RT-PCR analysis showed the specificity of siRNAs. TRPM2 siRNA transfection reduced TRPM2 transcript expression by 75% without affecting expression of TRPM7 or GAPDH (Figure 4B). Control siRNA had no effect on TRPM2 expression (Figure 4B). We determined the percentage of fluorescent cells by confocal imaging. Without siRNA, 85% to 90% of cells were fluorescent (Figure 4C, left). TRPM2 siRNAs greatly reduced this percentage and the fluorescent intensity (Figure 4C, center). Nonspecific siRNA was ineffective (Figure 4C, right). HPAE cells were plated to confluence on gold electrodes without or with siRNA, and TER was measured. TRPM2 silencing reduced the TER response to H2O2 (300 µmol/L) by 42% relative to control (no siRNA transfection) or negative control (nonspecific siRNA transfection; Figure 4D).
Transduction of TRPM2-S Inhibits H2O2-Induced Ca2+ Entry and Endothelial Hyperpermeability
The short splice variant of the functional channel, TRPM2-S, acts in a dominant-negative fashion to inhibit TRPM2-L activity.24,25 We overexpressed TRPM2-S in HPAE cells to determine its effects on H2O2-mediated responses. To quantify the expression level of TRPM2-S, we transfected HPAE cells with the fluorescent fusion protein GFP–TRPM2-S. We divided the cells for use in parallel determinations of intracellular Ca2+ and TER changes. Confocal imaging showed that 80% of cells expressed GFP–TRPM2-S (Figure 5A). RT-PCR analysis demonstrated that construct overexpression did not alter expression of endogenous TRPM2-L isoform (Figure 5B). Using the Ca2+ add-back protocol, we observed that overexpression of GFP–TRPM2-S inhibited H2O2-mediated (300 µmol/L) Ca2+entry by 83±13% (Figure 5C). Overexpression of GFP–TRPM2-S also attenuated the peak TER response to H2O2 (300 µmol/L) by 31±10% and markedly reduced its duration (Figure 5D, n=4).
|
Overexpression of TRPM2-L Augments H2O2-Induced Ca2+ Entry and Endothelial Hyperpermeability
If the balance between short and long TRPM2 isoforms determines channel activity, overexpression of TRPM2-L should enhance H2O2 effects; thus, we transfected HPAE cells with the fluorescent BFP–TRPM2-L isoform (see Figure 4) and monitored H2O2 responses (Figure 6). H2O2 addition increased Ca2+ entry above the vector control by 29±14% (Figure 6A; n=4) and also increased the TER response above the control by 151±7% (Figure 6B; n=4).
|
TRPM2 Blocking Antibody Prevents H2O2-Induced Endothelial Barrier Disruption
We next tested the blocking effect of a TRPM2 antibody (see Materials and Methods) on the TER response to H2O2. Confluent HPAE monolayers were treated overnight with either blocking antibody (5 µg/mL) or isotype-matched control antibody (5 µg/mL). Treatment with the specific antibody markedly reduced Ca2+ entry evoked by 300 µmol/L H2O2 compared with control (Figure 7A; n=3 for each group). TRPM2 antibody also diminished the TER response to H2O2 by 44±9% (Figure 7B; n=3); control antibody had no effect.
|
Inhibition of PARP Suppresses H2O2-Mediated Ca2+ Entry and Permeability Increase
TRPM2-L is activated by the binding of ADP-ribose to its binding cleft in TRPM2 carboxyl terminus.13 H2O2 stimulates PARP to generate ADP-ribose, whereas inhibitors of PARP prevent agonist formation.16 Therefore, we tested 2 PARP inhibitors, DPQ and 3-aminobenzamide (3-AB), for their ability to prevent H2O2 responses.16,28 HPAE cells were treated with 3-AB (1 mmol/L) or DPQ (100 µmol/L) for 45 minutes, and intracellular Ca2+ was measured in response to H2O2 (300 µmol/L) using the Ca2+ add-back protocol. Both 3-AB and DPQ significantly reduced Ca2+-repletion transients (60±11% and 62±9%, respectively) compared with untreated cells (Figure 8A). We obtained similar results in Ca2+-containing media on stimulating cells with H2O2 (300 µmol/L) (see Figure 8A, inset). In parallel experiments (Figure 8B), both PARP inhibitors also significantly reduced TER responses to H2O2 by 43±12% (3-AB) and 40±15% (DPQ).
|
| Discussion |
|---|
|
|
|---|
We observed that pathophysiologically relevant H2O2 concentrations of 100 to 300 µmol/L29 did not release Ca2+ from intracellular stores but did significantly stimulate extracellular Ca2+ entry, indicating that H2O2 (<300 µmol/L) does not activate store-operated channels in HPAE cells.30,31 We determined whether oxidants (
300 µmol/L) activated Ca2+ entry via TRPM2 channels by suppressing TRPM2 expression or activity by various means, eg, siRNAs, TRPM2-blocking antibody, overexpression of TRPM2-S, and PARP inhibitors that prevent generation of ADP-ribose.16,24,25,28 All of these interventions abolished H2O2-induced Ca2+ entry, indicating the crucial role of activation of TRPM2 channels in mediating Ca2+ entry caused by H2O2 in endothelial cells.
We also determined the role of TRPM2 in mediating the H2O2-induced decrease in TER resulting from opening of interendothelial junctions. Suppression of TRPM2 activity caused only a 50% reduction in the TER response of H2O2, suggesting that TRPM2 channels mediate approximately half of the permeability-increasing effect of H2O2. The residual effect of H2O2, which appears to be independent of Ca2+ entry, remains to be elucidated.
We showed that TRPM2-S overexpression suppressed Ca2+ entry and TER responses to H2O2 in endothelial cells. Importantly, the cells normally expressed both isoforms because the relative expression levels observed by real-time time RT-PCR were greater using the primer targeting both isoforms, as opposed to the primer specifically targeting the long form. TRPM2-S in human hematopoietic cells is generated by alternative splicing of the full-length protein.24 Coimmunoprecipitation and functional studies in HEK293T cells have also demonstrated direct interaction between short and long TRPM2 isoforms, resulting in suppression of H2O2-induced current and Ca2+ entry via TRPM2-L.24 Thus, endothelial responses to H2O2 may well depend on the relative abundance of the 2 isoforms.
Our electrophysiological observations suggest that a small population of TRPM2 channels can account for the whole-cell current induced by H2O2. Given an estimated single-channel conductance of 67 pS,20,32 and our observed whole-cell current of 125 pA (at –50 mV), we calculated
40 functional channels per cell. However, this apparent value presumably underestimates the actual expression of TRPM2 in the endothelial cell membrane because of the presence of the inhibitory short isoform TRPM2-S.
Lung endothelial injury, particularly in the setting of sepsis, is the result of oxidant generation by endothelial cells themselves and neutrophils and other inflammatory cells adherent to vessels.33,34 The generally held belief is that the resulting oxidants, including H2O2, directly damage endothelium.1–4 Our observations demonstrate a novel mechanism of H2O2-mediated disruption of endothelial barrier function that, in part, is attributable to a rise in intracellular Ca2+ mediated by Ca2+ entry through oxidant-sensitive TRPM2 channels. In this regard, increased microvessel endothelial permeability secondary to ischemia/reperfusion and neutrophil adhesion and activation may depend on H2O2-mediated activation of TRPM2 and influx of Ca2+. Therefore, inhibition of TRPM2 may provide a useful therapeutic strategy for the treatment of endothelial barrier dysfunction and vascular inflammation.
| Acknowledgments |
|---|
Sources of Funding
This work was supported in part by NIH training grants T32 HL007829 (to C.M.H.), P01 HL060678, and R01 HL045638.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Stevens T, Garcia JG, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol. 2000; 279: L419–L422.
3. Barnard ML, Matalon S. Mechanisms of extracellular reactive oxygen species injury to the pulmonary microvasculature. J Appl Physiol. 1992; 72: 1724–1729.
4. Lum H, Roebuck K. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol. 2001; 280: C719–C741.
5. Siflinger-Birnboim A, Goligorsky MS, Delvecchio PJ, Malik AB. Activation of protein kinase C pathway contributes to hydrogen peroxide-induced increase in endothelial permeability. Lab Invest. 1992; 67: 24–30.[Medline] [Order article via Infotrieve]
6. Dreher D, Junod AF. Differential effects of superoxide, hydrogen peroxide, and hydroxyl radical on intracellular calcium in human endothelial cells. J Cell Physiol. 1995; 162: 147–153.[CrossRef][Medline] [Order article via Infotrieve]
7. Volk T, Hensel M, Kox WJ. Transient Ca2+ changes in endothelial cells induced by low doses of reactive oxygen species: role of hydrogen peroxide. Mol Cell Biochem. 1997; 171: 11–21.[CrossRef][Medline] [Order article via Infotrieve]
8. Siflinger-Birnboim A, Lum H, del Vecchio PJ, Malik AB. Involvement of Ca2+ in the H2O2-induced increase in endothelial permeability. Am J Physiol Lung Cell Mol Physiol. 1996; 270: L973–L978.
9. Moore TM, Chetham PM, Kelly JJ, Stevens T. Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. Am J Physiol Lung Cell Mol Physiol. 1998; 275: L203–L222.
10. Chetham PM, Babal P, Bridges JP, Moore TM, Stevens T. Segmental regulation of pulmonary vascular permeability by store-operated Ca2+ entry. Am J Physiol Lung Cell Mol Physiol. 1999; 276: L41–L50.
11. Nagamine K, Kudoh J, Minoshima S, Kawasaki K, Asakawa S, Ito F, Shimizu N. Molecular cloning of a novel putative Ca2+ channel protein (TRPC7) highly expressed in brain. Genomics. 1998; 54: 124–131.[CrossRef][Medline] [Order article via Infotrieve]
12. Harteneck C, Plant TD, Schultz G. From worm to man: three subfamilies of TRP channels. Trends Neurosci. 2000; 23: 159–166.[CrossRef][Medline] [Order article via Infotrieve]
13. Perraud A-L, Fleig A, Dunn CA, Bagley LA, Launay P, Schmitz C, Stokes AJ, Zhu Q, Bessman MJ, Penner R, Kinet J-P, Scharenberg AM. ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology. Nature. 2001; 411: 595–599.[CrossRef][Medline] [Order article via Infotrieve]
14. Sano Y, Inamura K, Miyake A, Mochizuki S, Yokoi H, Matsushime H, Furuichi K. Immunocyte Ca2+ influx system mediated by LTRPC2. Science. 2001; 293: 1327–1330.
15. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, Yamada H, Shimizu S, Mori E, Kudoh J, Shimizu N, Kurose H, Okada Y, Imoto K, Mori Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death Mol Cell. 2002; 9: 163–173.[CrossRef][Medline] [Order article via Infotrieve]
16. Fonfria E, Marshall IC, Benham CD, Boyfield I, Brown JD, Hill K, Hughes JP, Skaper SD, McNulty S. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br J Pharmacol. 2004; 143: 186–92.[CrossRef][Medline] [Order article via Infotrieve]
17. Perraud AL, Takanishi CL, Shen B, Kang S, Smith MK, Schmitz C, Knowles HM, Ferraris D, Li W, Zhang J, Stoddard BL, Scharenberg AM. Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem. 2005; 280: 6138–6148.
18. Wehage E, Eisfeld J, Heiner I, Jungling E, Zitt C, Luckhoff A. Activation of the cation channel long transient receptor potential channel 2 (LTRPC2) by hydrogen peroxide. A splice variant reveals a mode of activation independent of ADP-ribose. J Biol Chem. 2002; 277: 23150–23156.
19. Perraud AL, Schmitz C, Scharenberg AM. TRPM2 Ca2+ permeable cation channels: from gene to biological function. Cell Calcium. 2003; 33: 519–53.[CrossRef][Medline] [Order article via Infotrieve]
20. Kraft R, Grimm C, Grosse K, Hoffmann A, Sauerbruch S, Kettenmann H, Schultz G, Harteneck C. Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia. Am J Physiol. 2004; 286: C129–C137.[CrossRef]
21. Heiner I, Eisfeld J, Halaszovich CR, Wehage E, Jungling E, Zitt C, Luckhoff A. Expression profile of the transient receptor potential (TRP) family in neutrophil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD. Biochem J. 2003; 371: 1045–1053.[CrossRef][Medline] [Order article via Infotrieve]
22. Kolisek M, Beck A, Fleig A, Penner R. Cyclic ADP-ribose and hydrogen peroxide synergize with ADP-ribose in the activation of TRPM2 channels. Mol Cell. 2005; 18: 61–69.[CrossRef][Medline] [Order article via Infotrieve]
23. Kühn FJ, Heiner I, Luckhoff A. TRPM2: a calcium influx pathway regulated by oxidative stress and the novel second messenger ADP-ribose. Pflugers Arch. 2005; 451: 212–219.[CrossRef][Medline] [Order article via Infotrieve]
24. Zhang W, Chu X, Tong Q, Cheung JY, Conrad K, Masker K, Miller BA. A novel TRPM2 isoform inhibits calcium influx and susceptibility to cell death. J Biol Chem. 2003; 278: 16222–16229.
25. Zhang W, Hirschler-Laszkiewicz I, Tong Q, Conrad K, Sun SC, Penn L, Barber DL, Stahl R, Carey DJ, Cheung JY, Miller BA. TRPM2 is an ion channel that modulates hematopoietic cell death through activation of caspases and PARP cleavage. Am J Physiol Cell Physiol. 2006; 290: C1146–C1159.
26. Paria BC, Malik AB, Kwiatek AM. Rahman A, May MJ, Ghosh S, Tiruppathi C. Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cells. J Biol Chem. 2003; 278: 37195–37203.
27. Suto MJ, Turner WR, Arundel-Suto CM, Werbel LM, Sebolt-Leopold JS. Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. Anticancer Drug Des. 1991; 6: 107–117.[Medline] [Order article via Infotrieve]
28. Miller BA. Inhibition of TRPM2 function by PARP inhibitors protects cells from oxidative stress-induced death. Br J Pharmacol. 2004; 143: 515–516.[CrossRef][Medline] [Order article via Infotrieve]
29. Ward PA. Mechanisms of endothelial cell killing by H2O2 or products of activated neutrophils. Am J Med. 1991; 91: 89S–94S.[CrossRef][Medline] [Order article via Infotrieve]
30. Miller BA. The role of TRP channels in oxidative stress-induced cell death. J Membrane Biol. 2006; 209: 1432–1424.
31. Hu Q, Corda S, Zweier JL, Capogrossi MC, Roy C. Hydrogen peroxide induces intracellular calcium oscillations in human aortic endothelial cells. Circ Res. 1998; 97: 268–275.[CrossRef]
32. Beck A, Kolisek M, Bagley LA, Fleig A, Penner R. Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. FASEB J. 2006; 20: 962–964.
33. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest. 1987; 80: 1550–1560.[Medline] [Order article via Infotrieve]
34. Wang Q, Doerschuk CM. Neutrophil-induced changes in the biomechanical properties of endothelial cells: roles of ICAM-1 and reactive oxygen species. J Immunol. 2000; 164: 6487–6494.
Related Article:
Circ. Res. 2008 102: 275-277.
This article has been cited by other articles:
![]() |
J. Du, J. Xie, and L. Yue Modulation of TRPM2 by acidic pH and the underlying mechanisms for pH sensitivity J. Gen. Physiol., November 16, 2009; (2009) jgp.200910254v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue and Z.-G. Xiong Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway Cardiovasc Res, August 1, 2009; 83(3): 547 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, J. Xie, and L. Yue Intracellular calcium activates TRPM2 and its alternative spliced isoforms PNAS, April 28, 2009; 106(17): 7239 - 7244. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, K. Wen, D. Yuan, L. Ai, and P. He Calcium influx-dependent differential actions of superoxide and hydrogen peroxide on microvessel permeability Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1096 - H1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xia, Z.-Z. Mei, H.-J. Mao, W. Yang, L. Dong, H. Bradley, D. J. Beech, and L.-H. Jiang Identification of Pore Residues Engaged in Determining Divalent Cationic Permeation in Transient Receptor Potential Melastatin Subtype Channel 2 J. Biol. Chem., October 10, 2008; 283(41): 27426 - 27432. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dietrich and T. Gudermann Another TRP to Endothelial Dysfunction: TRPM2 and Endothelial Permeability Circ. Res., February 15, 2008; 102(3): 275 - 277. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |